Literature DB >> 31564635

Mortality after bariatric surgery: findings from a 7-year multicenter cohort study.

Gretchen E White1, Anita P Courcoulas2, Wendy C King3, David R Flum4, Susan Z Yanovski5, Alfons Pomp6, Bruce M Wolfe7, Konstantinos Spaniolas8, Walter Pories9, Steven H Belle10.   

Abstract

BACKGROUND: Patients having bariatric surgery have lower mortality compared with those with similar body mass index who do not undergo surgery. It is unclear whether mortality post-bariatric surgery is similar to the general population. The benefit of bariatric surgery would be highlighted should people previously at high risk for premature death have comparable, or better, mortality as the general population.
OBJECTIVE: To compare mortality after bariatric surgery to the general U.S. population of the same age, sex, and race.
SETTING: The Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) prospective cohort of 2458 adults who underwent bariatric surgery at 10 U.S. hospitals between 2006 and 2009.
METHODS: Deaths were identified via LABS-2 follow-up and the National Death Index. Standardized mortality ratios (SMR) of post-bariatric surgery mortality observed in LABS-2 versus age-, sex-, race-, and year-adjusted expected mortality in the general U.S. population were calculated and compared with 1, which results when the number of observed and expected deaths are equal.
RESULTS: LABS-2 median follow-up was 6.6 (interquartile range: 5.9-7.0) years postsurgery. Seventy-six deaths were observed over 15,616 person-years (PY) of observation (4.9 deaths/1000 PY). The rate expected in the general U.S. population with the same age, sex, race, and year distribution was 4.8 deaths per 1000 PY (SMR = 1.02, 95% confidence interval [CI]: .80-1.27). There were no significant differences between observed and expected mortality by surgical procedure. Compared with expected mortality in the general U.S. population, people 35-44 years old at time of surgery had significantly more deaths (SMR = 2.06, 95% CI: 1.22-3.25), while people at least 55 years of age had significantly fewer (SMR = .63, 95% CI: .42-.92). Significantly more deaths than expected occurred in the perioperative period and 5-7 years after surgery.
CONCLUSIONS: Mortality within 7 years of bariatric surgery is comparable to the general U.S. population, which is likely to have better survival than people with severe obesity. However, more deaths than expected were identified 5-7 years after surgery.
Copyright © 2019 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Laparoscopic adjustable gastric banding; Long-term mortality; Mortality; Roux-en-Y gastric bypass

Year:  2019        PMID: 31564635      PMCID: PMC6834906          DOI: 10.1016/j.soard.2019.08.015

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  41 in total

Review 1.  A primer and comparative review of major US mortality databases.

Authors:  Diane C Cowper; Joseph D Kubal; Charles Maynard; Denise M Hynes
Journal:  Ann Epidemiol       Date:  2002-10       Impact factor: 3.797

Review 2.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1987

3.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

4.  Smoking and mortality--beyond established causes.

Authors:  Brian D Carter; Christian C Abnet; Diane Feskanich; Neal D Freedman; Patricia Hartge; Cora E Lewis; Judith K Ockene; Ross L Prentice; Frank E Speizer; Michael J Thun; Eric J Jacobs
Journal:  N Engl J Med       Date:  2015-02-12       Impact factor: 91.245

5.  Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients.

Authors:  Nicolas V Christou; John S Sampalis; Moishe Liberman; Didier Look; Stephane Auger; Alexander P H McLean; Lloyd D MacLean
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

6.  Long-term mortality rates (>8-year) improve as compared to the general and obese population following bariatric surgery.

Authors:  Dana A Telem; Mark Talamini; A Laurie Shroyer; Jie Yang; Maria Altieri; Qiao Zhang; Gerald Gracia; Aurora D Pryor
Journal:  Surg Endosc       Date:  2014-07-19       Impact factor: 4.584

Review 7.  Effects of Bariatric Surgery on Mortality, Cardiovascular Events, and Cancer Outcomes in Obese Patients: Systematic Review and Meta-analysis.

Authors:  Xu Zhou; Jiajie Yu; Ling Li; Viktoria Luise Gloy; Alain Nordmann; Maria Tiboni; Youping Li; Xin Sun
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

8.  US County-Level Trends in Mortality Rates for Major Causes of Death, 1980-2014.

Authors:  Laura Dwyer-Lindgren; Amelia Bertozzi-Villa; Rebecca W Stubbs; Chloe Morozoff; Michael J Kutz; Chantal Huynh; Ryan M Barber; Katya A Shackelford; Johan P Mackenbach; Frank J van Lenthe; Abraham D Flaxman; Mohsen Naghavi; Ali H Mokdad; Christopher J L Murray
Journal:  JAMA       Date:  2016-12-13       Impact factor: 56.272

9.  Deaths Attributable to Diabetes in the United States: Comparison of Data Sources and Estimation Approaches.

Authors:  Andrew Stokes; Samuel H Preston
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

Review 10.  Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.

Authors:  Katherine M Flegal; Brian K Kit; Heather Orpana; Barry I Graubard
Journal:  JAMA       Date:  2013-01-02       Impact factor: 56.272

View more
  1 in total

Review 1.  AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.

Authors:  Heather Patton; Julie Heimbach; Arthur McCullough
Journal:  Clin Gastroenterol Hepatol       Date:  2020-10-22       Impact factor: 11.382

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.